WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016091399) VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/091399    International Application No.:    PCT/EP2015/060756
Publication Date: 16.06.2016 International Filing Date: 15.05.2015
IPC:
C07H 15/04 (2006.01), A61K 31/7028 (2006.01), A61P 31/04 (2006.01)
Applicants: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. [DE/DE]; Hofgartenstrasse 8 80539 Munich (DE)
Inventors: SEEBERGER, Peter H.; (DE).
PEREIRA, Claney Lebev; (DE).
ANISH, Chakkumkal; (NL).
GEISSNER, Andreas; (DE)
Agent: ARTH, Hans-Lothar; (DE)
Priority Data:
14197832.0 12.12.2014 EP
15163253.6 10.04.2015 EP
Title (EN) VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4
(FR) VACCINS CONTRE LE SÉROTYPE 4 DU STREPTOCOCCUS PNEUMONIAE
Abstract: front page image
(EN)The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 4 capsular polysaccharide and conjugates thereof. Said conjugate and a pharmaceutical composition containing said conjugate are useful for prevention and/or treatment of diseases associated with Streptococcus pneumoniae, and more specifically of diseases associated with Streptococcus pneumoniae serotype 4. Furthermore, the synthetic saccharides of general formula (I) are useful as marker in immunological assays for detection of antibodies against Streptococcus pneumoniae bacteria.
(FR)La présente invention concerne des saccharides synthétiques de la formule générale (I), qui sont liés au polysaccharide de capsule du sérotype 4 du streptococcus pneumoniae, et leurs conjugués. Ledit conjugué et une composition pharmaceutique contenant ledit conjugué sont utiles pour la prévention et/ou le traitement de maladies associées au streptococcus pneumoniae et, plus précisément, de maladies associées au sérotype 4 du streptococcus pneumoniae. En outre, les saccharides de synthèse de la formule générale (I) sont utiles comme marqueur dans des analyses immunologiques de détection d'anticorps contre les bactéries streptococcus pneumoniae.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)